These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 8798970)

  • 21. Is there a role for immunotherapy in controlling HIV infection?
    Lederman MM
    AIDS Read; 2000 Apr; 10(4):209-16. PubMed ID: 10808604
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antiviral hyperactivation-limiting therapeutics as a novel class for the treatment of HIV/AIDS: focus on VS411.
    Uglietti A; Maserati R
    Expert Opin Investig Drugs; 2011 Apr; 20(4):559-65. PubMed ID: 21391888
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Immunopathogenesis of human immunodeficiency virus: implications for immune-based therapies.
    Sereti I; Lane HC
    Clin Infect Dis; 2001 Jun; 32(12):1738-55. PubMed ID: 11360217
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Gene therapy in HIV infection and other viral infections].
    Frøland SS
    Tidsskr Nor Laegeforen; 2001 Feb; 121(4):473-8. PubMed ID: 11255866
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Vaccine and immunotherapeutic interventions.
    Pantaleo G; Lévy Y
    Curr Opin HIV AIDS; 2013 May; 8(3):236-42. PubMed ID: 23478912
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Resistance to HIV-1 infection: lessons learned from studies of highly exposed persistently seronegative (HEPS) individuals.
    Kulkarni PS; Butera ST; Duerr AC
    AIDS Rev; 2003; 5(2):87-103. PubMed ID: 12876898
    [TBL] [Abstract][Full Text] [Related]  

  • 27. HIV immunopathogenesis.
    Brennan C; Porche DJ
    J Assoc Nurses AIDS Care; 1997; 8(4):7-22. PubMed ID: 9260148
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Immune interventions in HIV infection.
    Carcelain G; Autran B
    Immunol Rev; 2013 Jul; 254(1):355-71. PubMed ID: 23772631
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Study of the impact of HIV genotypic drug resistance testing on therapy efficacy.
    Van Vaerenbergh K
    Verh K Acad Geneeskd Belg; 2001; 63(5):447-73. PubMed ID: 11813503
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Improving immune function and controlling viral replication in HIV-1-infected patients with immune-based therapies.
    Angel JB
    AIDS Read; 2001 Apr; 11(4):209-21. PubMed ID: 11392678
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Challenges in the therapy of HIV infection.
    Yarchoan R; Mitsuya H; Broder S
    Immunol Today; 1993 Jun; 14(6):303-9. PubMed ID: 8397771
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Combination therapies against HIV-1 infection: exploring the concept of combining antiretroviral drug treatments with HIV-1 immune-based therapies in asymptomatic individuals.
    Ferre F; Moss RB; Daigle AE; Trauger RJ; Richieri SP; Jensen FC; Carlo DJ
    AIDS Patient Care STDS; 1996 Dec; 10(6):357-61. PubMed ID: 11361552
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Elite controllers as a model of functional cure.
    Autran B; Descours B; Avettand-Fenoel V; Rouzioux C
    Curr Opin HIV AIDS; 2011 May; 6(3):181-7. PubMed ID: 21460722
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Honing the immune attack on HIV.
    Gilden D
    GMHC Treat Issues; 1996 Dec; 10(12):8-11. PubMed ID: 11364019
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Therapeutic vaccines against HIV infection.
    García F; León A; Gatell JM; Plana M; Gallart T
    Hum Vaccin Immunother; 2012 May; 8(5):569-81. PubMed ID: 22634436
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mathematical models of HIV pathogenesis and treatment.
    Wodarz D; Nowak MA
    Bioessays; 2002 Dec; 24(12):1178-87. PubMed ID: 12447982
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Treatment research priorities for human immunodeficiency virus infection.
    Pettinelli CB; Schnittman SM
    Infect Agents Dis; 1993 Oct; 2(5):291-303. PubMed ID: 8173814
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Immune-based therapies and HIV infection].
    Weiss L
    Ann Med Interne (Paris); 2002 Jun; 153(4):227-36. PubMed ID: 12218888
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [New knowledge and new challenges: 4th National Conference on Retroviruses & Opportunistic Infections].
    Agosto M; Ehara R
    Sidahora; 1997; ():18-21. PubMed ID: 11364490
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Identification and characterization of HIV-1 transmitted /founder viruses].
    Zhao JY; Ding JW; Mi ZY; Wei T; Cen S
    Yi Chuan; 2015 May; 37(5):419-25. PubMed ID: 25998429
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.